Skip to main content

Advertisement

Log in

Microneedle Array Patch (MAP) Consisting of Crosslinked Hyaluronic Acid Nanoparticles for Processability and Sustained Release

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Aims

Crosslinked hyaluronic acid (X-linked HA) is not suitable for making microneedles because of the low fluidity of X-linked HA hydrogel. Microneedles were fabricated using X-linked HA nanoparticles (X-linked HA-NPs) to utilize the sustained drug delivery capability of X-linked HA-NPs and to obtain the processability advantages of X-linked HA.

Method

The puncture performance of a microneedle array patch (MAP) made of crosslinked hyaluronic acid nanoparticles (X-linked HA-NP-MAP) was evaluated by insertion in vitro into porcine skin. After a predetermined attachment time, the remaining height of the X-linked HA-NP-MAP was measured to determine the dissolution rate. X-linked HA-NP-MAP and free HA-MAP containing Rhodamine B isothiocyanate-dextran were administered into the back skin of mice, and the relative fluorescent intensity in the back skin was measured over time.

Results

The puncture performance of the X-linked HA-NP-MAP was over 90%. The diameter of redispersed X-linked HA-NPs was same as that of the premolded X-linked HA-NPs. The dissolution rate was not different from that of free HA-MAP. In an in vivo experiment, X-linked HA-NP-MAP was administered into the mouse’s back skin successfully and the relative fluorescent intensity of X-linked HA-NP-MAP lasted longer than that of HA-MAP.

Conclusion

X-linked HA-NPs provide the biocompatibility, the processability of micromolding, sustained drug release, successful penetration into the skin, and relatively short insertion time for full disintegration of NPs in the skin. X-linked HA-NP-MAP can be used for various applications that require several days of sustained drug release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Abbreviations

Free HA:

Non-crosslinked HA

HA:

Hyaluronic acid

HA-MAP:

Microneedle array patch made of free hyaluronic acid

X-linked:

Crosslinked

X-linked HA-NP-MAP:

Microneedle array patch made of crosslinked hyaluronic acid nanoparticles

X-linked HA-NP:

Crosslinked hyaluronic acid nanoparticle

References

  1. Jeong H-R, Lee H-S, Choi I-J, Park J-H. Considerations in the use of microneedles: pain, convenience, anxiety and safety. J Drug Target. 2017;25:29–40.

    Article  CAS  Google Scholar 

  2. Marshall S, Sahm LJ, Moore AC. The success of microneedle-mediated vaccine delivery into skin. Hum Vacc Immunother. 2016;12:2975–83.

    Article  Google Scholar 

  3. Hao Y, Li W, Zhou X, Yang F, Qian Z. Microneedles-based transdermal drug delivery systems: a review. J Biomed Nano Technol. 2017;13:1581–97.

    Article  CAS  Google Scholar 

  4. Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol. 2017;8:177–200.

    Article  CAS  Google Scholar 

  5. Arya J, Henry S, Kalluri H, McAllister DV, Pewin WP, Prausnitz MR. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1–7.

    Article  CAS  Google Scholar 

  6. Ita K. Dissolving microneedles for transdermal drug delivery: advances and challenges. Biomed Pharmacother. 2017;93:1116–27.

    Article  CAS  Google Scholar 

  7. Bhatnagar S, Dave K, Venuganti VVK. Microneedles in the clinic. J Cotrol Res. 2017;260:164–82.

    Article  CAS  Google Scholar 

  8. Kennedy J, Larrañeta E, McCrudden MT, McCrudden CM, Brady AJ, Fallows SJ, et al. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles. J Cotrol Res. 2017;265:57–65.

    Article  CAS  Google Scholar 

  9. Mc Crudden MT, Larrañeta E, Clark A, Jarrahian C, Rein-Weston A, Lachau-Durand S, et al. Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension. J Cotrol Res. 2018;292:119–29.

    Article  CAS  Google Scholar 

  10. Donnellyand RF, Larrañeta E. Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. Drug Discov Today. 2018;23:1026–33.

    Article  Google Scholar 

  11. DeMuth PC, Su X, Samuel RE, Hammond PT, Irvine DJ. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv Mater. 2010;22:4851–6.

    Article  CAS  Google Scholar 

  12. Du H, Liu P, Zhu J, Lan J, Li Y, Zhang L, et al. Hyaluronic acid dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019.

  13. Liu S, Wu D, Quan Y-s, Kamiyama F, Kusamori K, Katsumi H, et al. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid. Mol Pharm. 2015;13:272–9.

    Article  Google Scholar 

  14. Highley CB, Prestwich GD, Burdick JA. Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr Opin Biotechnol. 2016;40:35–40.

    Article  CAS  Google Scholar 

  15. Moillard S, Bétemps JB, Hadjab B, Topchian D, Micheels P, Salomon D. Key rheological properties of hyaluronic acid fillers: from tissue integration to product degradation. Plast Aesthet Res. 2018;5:17–24.

    Article  Google Scholar 

  16. Isa ILM, Abbah SA, Kilcoyne M, Sakai D, Dockery P, Finn DP, et al. Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury. Sci Adv. 2018;4:eaaq0597.

    Article  Google Scholar 

  17. Khunmanee S, Jeong Y, Park H. Crosslinking method of hyaluronic-based hydrogel for biomedical applications. J Tissue Eng. 2017;8:2041731417726464.

    Article  Google Scholar 

  18. Choi J-T, Park S-J, Park J-H. Microneedles containing cross-linked hyaluronic acid particulates for control of degradation and swelling behaviour after administration into skin. J Drug Target. 2018;26:884–94.

    Article  CAS  Google Scholar 

  19. Berkó S, Maroda M, Bodnár M, Erős G, Hartmann P, Szentner K, et al. Advantages of cross-linked versus linear hyaluronic acid for semisolid skin delivery systems. Eur Polym J. 2013;49:2511–7.

    Article  Google Scholar 

  20. Nakai T, Hirakura T, Sakurai Y, Shimoboji T, Ishigai M, Akiyoshi K. Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel. Macromol Biosci. 2012;12:475–83.

    Article  CAS  Google Scholar 

  21. Burdickand JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011;23:H41–56.

    Article  Google Scholar 

  22. Falconeand SJ, Berg RA. Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. J Biomed Mater Res. 2008;87:264–71.

    Article  Google Scholar 

  23. Al-Ghananeem AM, Malkawi AH, Muammer YM, Balko JM, Black EP, Mourad W, et al. Intratumoral delivery of paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations. AAPS PharmSciTech. 2009;10:410–7.

    Article  CAS  Google Scholar 

  24. Bodnár M, Daróczi L, Batta G, Bakó J, Hartmann JF, Borbély J. Preparation and characterization of cross-linked hyaluronan nanoparticles. Colloid Polym Sci. 2009;287:991–1000.

    Article  Google Scholar 

  25. Maroda M, Bodnár M, Berkó S, Bakó J, Erős G, Csányi E, et al. Preparation and investigation of a cross-linked hyaluronan nanoparticles system. Carbohydr Polym. 2011;83:1322–9.

    Article  CAS  Google Scholar 

  26. Vignesh S, Sivashanmugam A, Annapoorna M, Janarthanan R, Subramania I, Jayakumar R. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis. Colloid Surface B. 2018;161:129–38.

    Article  CAS  Google Scholar 

  27. Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. J Cotrol Res. 2015;205:144–54.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

This work was supported by the Industrial Strategic Technology Development Program (10067809: Development of vaccine formulation and patient-convenient vaccine microneedle), funded by the Ministry of Trade, Industry & Energy (MOTIE, South Korea), and by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2971, HI18C0590).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jae Myun Lee or Jung-Hwan Park.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, DS., Choi, JT., Kim, C.B. et al. Microneedle Array Patch (MAP) Consisting of Crosslinked Hyaluronic Acid Nanoparticles for Processability and Sustained Release. Pharm Res 37, 50 (2020). https://doi.org/10.1007/s11095-020-2768-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11095-020-2768-3

Key Words

Navigation